REQUEST A DEMO
Total
USD $0.00
Search more companies

GlaxoSmithKline EOOD (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Scientific Research and Development Services
Full name: GlaxoSmithKline EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

GlaxoSmithKline EOOD is a global biopharmaceutical company located in Sofia. The company aims to unite science, technology, and talent to combat diseases. Their goal is to positively impact the health of 2.5 billion people over the next 10 years. GSK's innovations and research and development efforts focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology. In Bulgaria, the company collaborates with partners to deliver medicines and vaccines to patients.

Headquarters
ul. Nedelcho Bonchev 16
Sofia; Sofia - city; Postal Code: 1592

Contact Details: Purchase the GlaxoSmithKline EOOD report to view the information.

Website: http://www.gsk.bg/

Basic Information
Total Employees:
Purchase the GlaxoSmithKline EOOD report to view the information.
Outstanding Shares:
Purchase the GlaxoSmithKline EOOD report to view the information.
Registered Capital:
Purchase the GlaxoSmithKline EOOD report to view the information.
Financial Auditors:
Purchase the GlaxoSmithKline EOOD report to view the information.
Incorporation Date:
October 31, 2003
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after GlaxoSmithKline EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
-37.22%
Total operating revenue
-37.16%
Operating profit (EBIT)
-35.34%
EBITDA
-43.95%
Net Profit (Loss) for the Period
-44.49%
Total assets
-44.34%
Total equity
7.94%
Operating Profit Margin (ROS)
0.11%
Net Profit Margin
-0.37%
Return on Equity (ROE)
-6.95%
Quick Ratio
13.09%
Cash Ratio
10.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?